Abiomed (ABMD) Posts Q2 Loss of $0.21, In-Line with Estimates
More News related to ABMD
- Abiomed Inc. (ABMD) Posts Q3 Loss of $0.12, Narrower than Estimated
- Abiomed (ABMD) Reports Smaller-Than-Expected Q3 Loss
- Trading Radar for 02/04: Bunge (BG), Spectra Energy (SE), MasterCard (MA), Con-Way (CNW), Hospira (HSP) Report
- Abiomed Third Fiscal Quarter 2010 Earnings and Conference Call Notification
- Abiomed Announces Partnership with Opsens to Utilize Sensor Technology for Impella
More News related to Earnings
- HNI Corporation (HNI) Tops Q1 EPS by 2c; Revs Light
- Team Health (TMH) Reports Mixed Q4 Results
- Baidu (BIDU) Blows the Lid Off Q4, Shares Jump
- Aspen Insurance (AHL) Posts Q4 adj.-EPS of $1.44, Tops Views
- Acadia Realty Trust (AKR) Misses Q4 FFO by 1c; Guides Below for FY10
Abiomed, Inc. (NASDAQ: ABMD) reports Q2 loss of $0.21, even with the analyst estimate of ($0.21). Revenue for the quarter was $20.02 million, which compares to the estimate of $20.14 million.
Related Categories
EarningsStocks Mentioned
+0.48Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
